share_log

普利制药:关于注射用达托霉素获得德国联邦药物与医疗器械所(BfArM)上市许可的公告

Puri Pharmaceuticals: Announcement on Daptomycin for injections obtained marketing approval from the German Federal Institute for Drugs and Medical Devices (BfArM)

深证信a股 ·  Apr 3
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more